Seguimiento ginecológico de la mujer con infección por el virus de la inmunodeficiencia humana

Morlat P. Prise en charge médicale des personnes infectées par le VIH. Rapport 2017. La documentation Française ; p. 297-337. Accessible sur : https://cns.sante.fr/actualites/prise-en-charge-du-vih-recommandations-du-groupe-dexperts/. Costagliola D. FHDH retour d’informations 2011. Accessible sur : http://www.ccde.fr/_fold/fl-1309770710-517.pdf. Mandelblatt, 1992, Association between HIV infection and cervical neoplasia: implications for clinical care of women at risk for both conditions, AIDS, 6, 173, 10.1097/00002030-199202000-00005 Ferenczy, 2003, Human papillomavirus and HIV coinfection and the risk of neoplasias of the lower genital tract: a review of recent developments, CMAJ, 169, 431 Massad, 2009, Long-term incidence of cervical cancer in women with human immunodeficiency virus, Cancer, 115, 524, 10.1002/cncr.24067 Ezechi, 2010, Effect of HIV-1 infection and increasing immunosuppression on menstrual function, J Obstet Gynaecol Res, 36, 1053, 10.1111/j.1447-0756.2010.01253.x Wilson, 2010, HIV infection and women's sexual functioning, J Acquir Immune Defic Syndr, 54, 360, 10.1097/QAI.0b013e3181d01b14 Duerr, 2003, Incident and persistent vulvovaginal candidiasis among human immunodeficiency virus-infected women: risk factors and severity, Obstet Gynecol, 101, 548 Massad, 2004, Effect of antiretroviral therapy on the incidence of genital warts and vulvar neoplasia among women with the human immunodeficiency virus, Am J Obstet Gynecol, 190, 1241, 10.1016/j.ajog.2003.12.037 Loutfy, 2013, Systematic review of HIV transmission between heterosexual serodiscordant couples where the HIV-positive partner is fully suppressed on antiretroviral therapy, PLoS One, 8, e55747, 10.1371/journal.pone.0055747 Fan, 2008, HIV and the menopause, Menopause Int, 14, 163, 10.1258/mi.2008.008027 Weller, 2002, Condom effectiveness in reducing heterosexual HIV transmission, Cochrane Database Syst Rev, CD003255